Partial deletions of the CDKN2 and MTS2 putative tumor suppressor genes in a myxoid chondrosarcoma
- 19 July 1996
- journal article
- Published by Elsevier BV in Cancer Letters
- Vol. 105 (1), 77-90
- https://doi.org/10.1016/0304-3835(96)04273-5
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinomaNature Genetics, 1994
- Rates of p16 ( MTS1 ) Mutations in Primary Tumors with 9p LossScience, 1994
- Biologic and clinical significance of cytogenetic and molecular cytogenetic abnormalities in benign and malignant cartilaginous lesionsCancer Genetics and Cytogenetics, 1993
- Cytogenetic Findings in a Metastasizing Primary Testicular ChondrosarcomaThe American Journal of Surgical Pathology, 1993
- Cytogenetic and molecular cytogenetic techniques in orthopaedic surgery.The Journal of Bone & Joint Surgery, 1993
- A genetic model for colorectal tumorigenesisCell, 1990
- Deletions of Interferon Genes in Acute Lymphoblastic LeukemiaThe New England Journal of Medicine, 1990
- Complex cytogenetic aberrations in a well-differentiated chondrosarcomaCancer Genetics and Cytogenetics, 1989
- Cytogenetic Analysis of Melanocytes From Premalignant Nevi and MelanomasJNCI Journal of the National Cancer Institute, 1988
- Recurrent breakpoints at 9q31 and 22q12.2 in extraskeletal myxoid chondrosarcomaCancer Genetics and Cytogenetics, 1988